Press Release dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion Kaiseraugst (Switzerland), ...

LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United ...

STMicroelectronics Announces Status ofCommon Share Repurchase Program Disclosure of Transactions in Own Shares – Period from May 26, 2025 to May ...

EQS-News: Gerresheimer AG / Key word (s): Change in Forecast/Dividend Gerresheimer Adjusts Guidance for Financial Year 2025 02.06.2025 / 12:18 CET/CEST The issuer is solely responsible for the ...

Total Voting Rights . On 30 May 2025, the issued share capital of the Company with voting rights was 366,176,532 ordinary shares of £0.01 each. No ordinary shares a ...

The following notification is made in accordance with the UK Financial Conduct Authority Disclosure and Transparency Rule 5.6.1. As at 31 May 2025, the Company’s issued share capital consisted of ...

Nasdaq CopenhagenEuronext Dublin London Stock ExchangeDanish FSAOther stakeholders Date    2 June 2025 Implementation of share buyback ...

The Singapore stock market on Friday ended the three-day winning streak in which it had advanced more than 40 points or 1 percent.

The Japan stock market has finished lower in two of three trading days since the end of the three-day winning streak in which it had ...

Novartis is announcing data from a new subgroup analysis of the Phase III NATALEE trial evaluating the efficacy and safety of Kisqali(R) (ribociclib) plus endocrine therapy (ET, a non-steroidal ...

WithSecure Corporation, Stock Exchange Release, 31 May 2025 at 9:45 EEST WithSecure has completed the transaction of Cyber security consulting ...

Consumer prices in the U.S. crept slightly higher in the month of April, according to a closely watched report released by the ...